hydrazine has been researched along with Colorectal Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, X; Li, Y; Lin, Y; Qian, X; Tao, L; Yang, S; Zhang, H; Zhao, Y; Zuo, Z | 1 |
| Christgen, S; Kanneganti, TD; Karki, R; Lee, S; Malireddi, RKS; Neale, G; Nguyen, LN; Samir, P; Sharma, BR; Sundaram, B; Vogel, P; Wang, Y; Zheng, M | 1 |
| Aladhraei, M; Kassem Al-Thobhani, A; Poungvarin, N; Suwannalert, P | 1 |
| Amberg, S; Bokemeyer, C; Kranich, AL; Mann, J; Nilsson, S; Papadimitriou, K; Rolfo, C; Stein, A; Theile, S | 1 |
| Abdelhamid, AO; Alalawy, AI; Ali, AG; Almutairi, FM; Bishr, MK; Mohamed, MS | 1 |
| Abdel-Aziz, HA; Abdulla, M; Abo-Ashour, MF; Ahmad, R; Al-Khayal, K; Al-Rashood, ST; Al-Warhi, T; Alharbi, A; Ayyad, RR; El-Haggar, R; Eldehna, WM | 1 |
| Arai, H; Inui, A; Wakabayashi, H | 1 |
| Duan, J; Gao, W; Huang, C; Huang, Z; Lin, J; Nice, EC | 1 |
| Adam, F; Al-Juaid, S; Al-Suede, FSR; Arafath, MA; Khadeer Ahamed, MB; Majid, AMSA | 1 |
| Liu, L; Lu, H; Wang, C; Yu, M; Zhang, Y | 1 |
| Cheng, PC; Chiang, PF; Chuang, TW; Lin, WJ; Luo, TY; Yeh, CH | 1 |
| Jia, Y; Meng, L; Tian, K; Wang, Z; Xu, G; Xu, X; Yuan, H; Zhou, S; Zhou, W | 1 |
| Chen, W; Cui, L; Fang, S; Hou, X; Huang, YY; Li, HQ; Liu, CY; Ouyang, X; Wang, G; Wu, T; Yang, Y; Yu, T; Zhong, Y | 1 |
| Hilborn, J; Ossipov, DA; Sun, W; Varghese, OP | 1 |
| Cobau, CD; Gerstner, JB; Gesme, DH; Goldberg, RM; Kuross, SA; Loprinzi, CL; O'Fallon, JR; Rospond, RM | 1 |
2 trial(s) available for hydrazine and Colorectal Neoplasms
| Article | Year |
|---|---|
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Topics: Active Transport, Cell Nucleus; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Hydrazines; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Prognosis; Survival Rate; Triazoles | 2020 |
Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Hydrazines; Male; Middle Aged; Quality of Life; Survival Rate | 1994 |
13 other study(ies) available for hydrazine and Colorectal Neoplasms
| Article | Year |
|---|---|
Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
Topics: Colorectal Neoplasms; Female; HCT116 Cells; HeLa Cells; Histone Demethylases; Humans; Hydrazines; Lipid Metabolism; Lipidomics; Morpholines; Sulfones; Uterine Cervical Neoplasms | 2021 |
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
Topics: Adenosine Deaminase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Transformation, Neoplastic; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazines; Interferon-gamma; Male; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Necroptosis; Pyroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Signal Transduction; Skin Neoplasms; Triazoles | 2021 |
Association of XPO1 Overexpression with NF-κB and Ki67 in Colorectal Cancer.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Colorectal Neoplasms; Exportin 1 Protein; Female; Follow-Up Studies; HT29 Cells; Humans; Hydrazines; Karyopherins; Ki-67 Antigen; Lymphatic Metastasis; Male; Middle Aged; NF-kappa B; Prognosis; Receptors, Cytoplasmic and Nuclear; Triazoles; Young Adult | 2019 |
The Identification of a Novel Unsymmetrical Azine as an Apoptosis Inducer in Colorectal Cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Development; Drug Screening Assays, Antitumor; Humans; Hydrazines; Indoles; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |
The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
Topics: Cachexia; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Humans; Hydrazines; Japan; Lung Neoplasms; Oligopeptides; Pancreatic Neoplasms | 2021 |
Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A.
Topics: Colorectal Neoplasms; Copper; Copper-Transporting ATPases; Ferroptosis; Humans; Hydrazines; Peptide Fragments; Tumor Microenvironment | 2021 |
Schiff base-nickel, palladium, and platinum complexes derived from N-cyclohexyl hydrazine carbothioamide and 3-hydroxy-4-methoxybenzaldehyde: Selective antiproliferative and proapoptotic effects against colorectal carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Line; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Humans; Hydrazines; Ligands; Molecular Docking Simulation; Nickel; Palladium; Platinum; Protein-Tyrosine Kinases; Schiff Bases; Thioamides | 2019 |
Hydrazide functionalized core-shell magnetic nanocomposites for highly specific enrichment of N-glycopeptides.
Topics: Chromatography, High Pressure Liquid; Colorectal Neoplasms; Ferrosoferric Oxide; Glycopeptides; Glycoproteins; Humans; Hydrazines; Magnetics; Nanocomposites; Polymethacrylic Acids; Proteomics; Signal-To-Noise Ratio; Tandem Mass Spectrometry | 2014 |
188Re-HYNIC-trastuzumab enhances the effect of apoptosis induced by trastuzumab in HER2-overexpressing breast cancer cells.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Flow Cytometry; Humans; Hydrazines; Membrane Potential, Mitochondrial; Nicotinic Acids; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Rhenium; Trastuzumab | 2015 |
Diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats.
Topics: Aberrant Crypt Foci; Animals; Colorectal Neoplasms; Diabetes Mellitus, Experimental; Hexokinase; Histological Techniques; Hydrazines; Male; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Kinase; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds | 2014 |
Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor.
Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Bortezomib; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colorectal Neoplasms; Drug Synergism; HCT116 Cells; HeLa Cells; Humans; Hydrazines; Mice; Proteasome Inhibitors; Triazoles; Tumor Suppressor Protein p53; Ubiquitination; Xenograft Model Antitumor Assays | 2017 |
In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach.
Topics: Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Diphosphonates; Drug Carriers; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Hydrazines; Hydrogel, Polyethylene Glycol Dimethacrylate; Kidney; Prodrugs | 2009 |